Prev Arrow Stocks

Chemours Company (The) ($CC) Stock Forecast: Down 6.7% Today

Morpher AI identified a bearish signal. The stock price may continue to fall based on the momentum of the negative news.

What is Chemours Company (The)?

Chemours Company (CC) is a chemical company listed on the NYSE, known for its products in areas such as refrigerants and titanium technologies. The company has been experiencing mixed sentiments from analysts despite recent market movements.

Why is Chemours Company (The) going down?

CC stock is down 6.7% on Dec 16, 2025 14:36

  • The stock of Chemours Company (CC) experienced a strong bearish movement today, possibly influenced by:
  • Concerns over the company's declining Q3 revenue, particularly in segments like Freon Refrigerants and Foam, Propellants & Other sales.
  • Negative sentiment stemming from the discovery of dangerous chemicals like GenX in the US water supply, traced back to a Chemours factory, raising environmental and health-related alarms.
  • Opposition from local authorities and utility organizations towards Chemours' expansion plans, reflecting ongoing public health concerns and the company's historical accountability issues.
  • These factors combined may have contributed to investor uncertainty and a bearish trend in CC's stock price.

CC Price Chart

CC Technical Analysis

CC News

Chemours Company (CC) Up More than 12% Since Q3, Here’s What Wall Street Thinks About the Stock

The Chemours Company (NYSE:CC) has seen its stock price increase by over 12% since its Q3 2025 results, despite subpar earnings. Wall Street analysts maintain a mixed outlook, with J.P. Morgan reiterating a Hold rating and lowering its price target, while Alembic Global maintained a Buy rating with a lowered price target. The company's Q3 revenue decreased year-over-year, attributed to declines in Freon Refrigerants and Foam, Propellants & Other sales, though offset by a significant increase in Opteon™ Refrigerants.

https://www.insidermonkey.com/blog/chemours-company-cc-up-more-than-12-since-q3-heres-what-wall-street-thinks-about-the-stock-1659830/?amp=1

0 News Article Image Chemours Company (CC) Up More than 12% Since Q3, Here’s What Wall Street Thinks About the Stock

Chemours Taps Industry Veteran to Lead Titanium Unit Through Next Phase

The Chemours Company has appointed Michael Foley as the new president of its Titanium Technologies business, effective February 2026. Foley, an industry veteran from Momentive Performance Materials, is expected to lead the unit's transformation towards improved profitability and value creation. This strategic leadership change underscores Chemours' commitment to its value-based strategy and operational excellence.

https://www.mychesco.com/a/news/regional/chemours-taps-industry-veteran-to-lead-titanium-unit-through-next-phase/

1 News Article Image Chemours Taps Industry Veteran to Lead Titanium Unit Through Next Phase

Experts issue warning after discovering dangerous substance in US water supply: '[They're] permitting someone to put something into the … water'

Water officials in Kentucky discovered a "sudden spike" in GenX, a dangerous "forever chemical," in the local drinking water sourced from the Ohio River. The contamination was traced to a Chemours factory in West Virginia, which had permission to discharge some chemicals but exceeded legal limits. Experts argue that legalized contamination is a flawed concept, and the costs of remediation are unfairly borne by taxpayers, while these "forever chemicals" are linked to serious health issues.

https://www.thecooldown.com/green-tech/genx-chemical-louisville-water-company-kentucky/

2 News Article Image Experts issue warning after discovering dangerous substance in US water supply: '[They're] permitting someone to put something into the … water'

The forever chemical TFA could cause irreversible harm. In Eastern North Carolina, it’s everywhere.

A new study by NC State and UNC scientists found high levels of TFA, a type of PFAS previously thought to be less harmful, in the blood and drinking water of Wilmington residents. This discovery raises significant concerns about Chemours' continued discharge of PFAS precursors, which break down into TFA, despite the chemical industry's claims of its low toxicity and the lack of federal drinking water standards for TFA. Environmental groups and local authorities are now urging stricter regulation and transparency from Chemours, particularly as the company plans an expansion of its Fayetteville Works plant.

https://ncnewsline.com/2025/12/12/the-forever-chemical-tfa-could-cause-irreversible-harm-in-eastern-north-carolina-its-everywhere/

3 Missing News Article Image The forever chemical TFA could cause irreversible harm. In Eastern North Carolina, it’s everywhere.

Spotlight On Chemours’ Expansion Plans

Local officials in Wilmington, New Hanover County, and the Cape Fear Public Utility Authority have unanimously opposed Chemours' plans to increase production at its Fayetteville plant, citing ongoing public health concerns related to PFAS chemicals and the company's historic lack of accountability. Despite Chemours' claims that upgrades would reduce PFAS emissions, critics remain skeptical, pointing to continued groundwater contamination and the significant costs incurred by the utility authority to filter out these "forever chemicals." The resolutions urge the state to prioritize public safety over increased production, highlighting the financial burden passed onto ratepayers.

https://www.wilmingtonbiz.com/more_news/2025/12/10/spotlight_on_chemours%E2%80%99_expansion_plans/27055

4 Missing News Article Image Spotlight On Chemours’ Expansion Plans

Chemours Company (The) Price History

30.09.2025 - CC Stock was down 5.2%

  • The downward trend in CC's stock today is possibly linked to the expected decrease in Q3 earnings.
  • Investor response might have been adverse due to concerns about CC falling short of anticipated earnings, resulting in a sell-off of shares.
  • Uncertainty surrounding CC's upcoming earnings announcement might have impacted the bearish market performance observed today.

09.11.2025 - CC Stock was down 0.5%

  • The denial of Chemours' plea to secure confidential documents by a federal judge could lead to enhanced transparency but has also sparked concerns regarding potential negative impacts on investor sentiment from the information that may be divulged.
  • The appointment of Michael Foley as President of Titanium Technologies may indicate advancements in operations, yet investor apprehension persists due to persisting issues like PFAS litigation and regulatory uncertainties, resulting in a mixed response from the market.
  • The legal triumph of Carneys Point Township to pursue a billion-dollar cleanup lawsuit against chemical manufacturers, which includes Chemours, underscores the continuous legal hurdles faced by the company, further pressuring its stock performance.
  • The objection from Brunswick County commissioners to Chemours' expansion proposals stemming from worries about PFAS emissions and water contamination showcases mounting scrutiny and opposition from local authorities, introducing additional uncertainties to the company's future growth outlook.

14.10.2025 - CC Stock was down 5.4%

  • CC reported a Q3 profit rebound with $60M in net income, fueled by strong performance in Thermal & Specialized Solutions.
  • Despite the positive earnings, the market reacted bearishly, possibly due to operational disruptions.
  • Investors might be concerned about the mixed segment results, leading to the bearish movement in CC's stock price today.

15.11.2025 - CC Stock was down 5.0%

  • Michael Foley's appointment as the new president of Chemours' Titanium Technologies business signifies the company's commitment to enhancing profitability and operational efficiency.
  • The presence of hazardous "forever chemicals" such as GenX and TFA in the water supply, linked to Chemours' activities, has sparked concerns among experts and local authorities.
  • Reservations from local officials and environmental groups regarding Chemours' expansion intentions at its Fayetteville plant mirror a growing doubt about the company's capability to tackle PFAS contamination matters and prioritize public safety over production expansion.
  • The continued controversy surrounding Chemours' release of PFAS precursors and the possible health hazards related to TFA underscore the necessity for stricter regulations and transparency in the chemical sector to avert irreversible harm to the environment and communities.

11.11.2025 - CC Stock was up 5.3%

  • Investors responded positively to the news of Michael Foley's appointment as the new President of Titanium Technologies at Chemours, fueling a bullish trend in the company's stock. This appointment is seen as a potential driver for operational enhancements and strategic changes.
  • Despite ongoing public health and environmental controversies linked to PFAS chemicals, including opposition to Chemours' expansion plans, investors seem to have focused more on the optimism surrounding Foley's leadership, resulting in a positive market sentiment.
  • The market sentiment towards Chemours appears to be balanced, with the potential positive impact of Foley's new role offsetting concerns related to PFAS contamination and regulatory challenges. This balancing act reflects a level of optimism for the company's future trajectory under Foley's leadership.
  • The increased investor confidence in Chemours may have been influenced by the denial of the company's request to seal documents related to PFAS discharges, suggesting a commitment to transparency and compliance, which could enhance trust and bolster investor sentiment.

16.11.2025 - CC Stock was down 6.7%

  • The stock of Chemours Company (CC) experienced a strong bearish movement today, possibly influenced by:
  • Concerns over the company's declining Q3 revenue, particularly in segments like Freon Refrigerants and Foam, Propellants & Other sales.
  • Negative sentiment stemming from the discovery of dangerous chemicals like GenX in the US water supply, traced back to a Chemours factory, raising environmental and health-related alarms.
  • Opposition from local authorities and utility organizations towards Chemours' expansion plans, reflecting ongoing public health concerns and the company's historical accountability issues.
  • These factors combined may have contributed to investor uncertainty and a bearish trend in CC's stock price.

25.08.2025 - CC Stock was down 5.1%

  • An investigation initiated by the former Louisiana Attorney General into The Chemours Company's officers and directors has raised concerns among investors about potential legal liabilities and corporate governance issues.
  • The news of the investigation has likely contributed to the bearish movement in CC's stock as investors fear the uncertainties and potential legal consequences that may arise from the probe.
  • Market sentiment towards CC may remain negative in the near term until more clarity is provided regarding the investigation and its potential impact on the company's operations and financial performance.

17.08.2025 - CC Stock was up 5.3%

  • Energy Fuels achieving a milestone in manufacturing EV-grade rare earth magnets may suggest an increasing demand for tech components, potentially favoring CC's semiconductor business.
  • Progress in the U.S.-based supply chain for rare earth magnets could improve production efficiency and cost-effectiveness for companies like CC.
  • This development reflects a positive trend in the tech industry, likely enhancing investor confidence in CC's future outlook and contributing to the uptrend in its stock price.

06.07.2025 - CC Stock was down 5.9%

  • The strong bearish movement in CC's stock today might be due to profit-taking by investors after the stock's recent positive performance.
  • Despite the earnings and revenue beats, investors might have been concerned about future guidance or market conditions, leading to the bearish trend.
  • It's possible that some investors were expecting even higher numbers from CC, causing disappointment and a sell-off in the stock.

07.10.2025 - CC Stock was down 11.2%

  • Chemours (CC) had a bearish movement today following a Q3 earnings report that missed estimates by -16.67%.
  • The observation of oversold materials stocks may not have been enough to counter the negative impact of the earnings miss on Chemours.
  • Investors reacted negatively to the company's financial performance, leading to a sell-off of the stock.
  • The market sentiment towards Chemours seems to have shifted due to the disappointing earnings results, overshadowing any potential buying opportunities in the materials sector.

21.07.2025 - CC Stock was down 6.0%

  • The partnership with SRF to enhance the supply chain and product mix demonstrates Chemours' proactive approach to adapt to market changes.
  • Despite the positive strategic move, investors might have reacted bearishly to the announcement, potentially due to concerns about short-term costs or uncertainties about the partnership's immediate impact on financials.
  • The bearish movement could also be influenced by broader market conditions or sector-specific challenges affecting chemical companies, leading to a sell-off in CC shares.

24.05.2025 - CC Stock was up 5.6%

  • The strong upsurge in Chemours' stock price is linked to the anticipated sales expansion in the second quarter, propelled by the growing demand for Opteon.
  • Chemours' capacity to confront disruptions in TT (potentially referencing a particular division or market sector) highlights its resilience and adept strategic oversight.
  • The market appears to be responding favorably to Chemours' adeptness in seizing growth prospects and handling obstacles efficiently, contributing to the surge in the stock value.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.